Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FSHD region gene 2 family member C, pseudogene (ENSG00000274892) is annotated as a **pseudogene** and does not code for a functional protein. Pseudogenes like this originate from duplication or retrotransposition events that render them nonfunctional due to disruption of coding sequence, loss of regulatory elements, or accumulation of disabling mutations[5][10]. Although some pseudogenes can play regulatory roles at the RNA level in certain contexts, this is not the rule and is not specifically described for this locus. Pseudogenes are retained in the genome as molecular fossils of former protein-coding genes and are not considered druggable therapeutic targets[5][10]. If structured information is needed for further mapping, this entry should be flagged as a non-target pseudogene to avoid inappropriate inclusion in target-based drug discovery pipelines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FSHD region gene 2 family member C, pseudogene.